BioCentury
ARTICLE | Company News

UC Regents issued second CRISPR patent in U.S.

November 2, 2018 7:59 PM UTC

The Regents of the University of California, the University of Vienna and Emmanuelle Charpentier were granted a patent by the U.S. Patent Office covering use of guide RNA formats in CRISPR-Cas9 gene editing technology. The claims cover protein/RNA compositions that can be used to deliver CRISPR-Cas9 into cells as either ribonucleoproteins or DNA-encoded components.

The patent, U.S. Patent No. 10,113,167, is the second related to CRISPR gene editing issued to the group in the U.S. and the first since the U.S. Court of Appeals for the Federal Circuit (CAFC) upheld a ruling against the group in September in the patent interference case against the Broad Institute of MIT and Harvard...